Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.150
-0.260 (-7.62%)
At close: Mar 6, 2026, 4:00 PM EST
3.240
+0.090 (2.86%)
After-hours: Mar 6, 2026, 7:59 PM EST
Sana Biotechnology Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Sana Biotechnology stock have an average target of 7.50, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 138.10% from the current stock price of 3.15.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sana Biotechnology stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +122.22% | Mar 4, 2026 |
| Wedbush | Wedbush | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +90.48% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +185.71% | Nov 7, 2025 |
| Citizens | Citizens | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +153.97% | Oct 30, 2025 |
| Wedbush | Wedbush | Buy Initiates $5 | Buy | Initiates | $5 | +58.73% | Sep 24, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.57
from -0.96
EPS Next Year
-0.61
from -0.57
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.40 | -0.39 | |||
| Avg | -0.57 | -0.61 | |||
| Low | -0.74 | -0.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.